LeonaBio, Inc. (LONA)
6.14
+0.39
(+6.78%)
USD |
NASDAQ |
Oct 12, 16:00
6.14
0.00 (0.00%)
After-Hours: 20:00
LeonaBio Enterprise Value : 3.685M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 3.685M |
| October 08, 2026 | 3.685M |
| October 07, 2026 | 4.438M |
| October 06, 2026 | 3.685M |
| October 05, 2026 | 2.083M |
| October 02, 2026 | -5.077M |
| October 01, 2026 | -9.223M |
| September 30, 2026 | -16.85M |
| September 29, 2026 | -17.42M |
| September 28, 2026 | -23.45M |
| September 25, 2026 | -19.87M |
| September 24, 2026 | -3.476M |
| September 23, 2026 | 5.004M |
| September 22, 2026 | 6.511M |
| September 21, 2026 | 9.149M |
| September 18, 2026 | 13.48M |
| September 17, 2026 | 14.99M |
| September 16, 2026 | 13.48M |
| September 15, 2026 | 17.72M |
| September 14, 2026 | 19.89M |
| September 11, 2026 | 14.71M |
| September 10, 2026 | 14.14M |
| September 09, 2026 | 15.84M |
| September 08, 2026 | 25.07M |
| September 04, 2026 | 20.74M |
| Date | Value |
|---|---|
| September 03, 2026 | 22.06M |
| September 02, 2026 | 21.77M |
| September 01, 2026 | 21.02M |
| August 31, 2026 | 24.13M |
| August 28, 2026 | 24.32M |
| August 27, 2026 | 23.85M |
| August 26, 2026 | 23.09M |
| August 25, 2026 | 24.98M |
| August 24, 2026 | 22.34M |
| August 21, 2026 | 21.92M |
| August 20, 2026 | 22.06M |
| August 19, 2026 | 23.28M |
| August 18, 2026 | 26.49M |
| August 17, 2026 | 22.15M |
| August 14, 2026 | 24.55M |
| August 13, 2026 | 23.66M |
| August 12, 2026 | 23.66M |
| August 11, 2026 | 21.30M |
| August 10, 2026 | 20.17M |
| August 07, 2026 | 21.87M |
| August 06, 2026 | 23.09M |
| August 05, 2026 | 21.87M |
| August 04, 2026 | 21.68M |
| August 03, 2026 | 19.89M |
| July 31, 2026 | 16.03M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cocrystal Pharma, Inc. | 13.85M |
| CNBX Pharmaceuticals, Inc. | 1.453M |
| Arvinas, Inc. | -60.81M |
| Fulcrum Therapeutics, Inc. | -25.97M |
| Definium Therapeutics, Inc. | 3.911B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.01M |
| Total Expenses (Quarterly) | 19.01M |
| EPS Diluted (Quarterly) | -0.8011 |
| Earnings Yield | -376.4% |
| Normalized Earnings Yield | -178.18 |